Human infections with novel reassortant H5N6 avian influenza viruses in China

Ye ZhangNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, China

Minmei ChenGuangxi Center for Disease Prevention and Control, Nanning530028, China

Yiwei HuangHunan Provincial Center for Disease Control and Prevention, Changsha410005, China

Wenfei ZhuNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, China

Lei YangNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, China

Lidong GaoHunan Provincial Center for Disease Control and Prevention, Changsha410005, China

Xiaodan LiNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, China

Fuyin BiGuangxi Center for Disease Prevention and Control, Nanning530028, China

Chaoyang HuangHunan Provincial Center for Disease Control and Prevention, Changsha410005, China

Ning KangGuangxi Center for Disease Prevention and Control, Nanning530028, China

Hengjiao ZhangHunan Provincial Center for Disease Control and Prevention, Changsha410005, China

Zi LiNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, China

Hong BoNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, China

Dayan WangNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, ChinaCorrespondence[email protected]

Yuelong ShuNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, ChinaCorrespondence[email protected]

show all

References

Pan M, Gao R, Lv Qet al.Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings. J Infect 2016;72: 52–59.
PubMed Web of Science ®Google Scholar
Bi Y, Chen Q, Wang Qet al.Genesis, evolution and prevalence of H5N6 avian influenza viruses in China. Cell Host Microbe 2016;20: 810–821.
PubMed Web of Science ®Google Scholar
Xu W, Li X, Bai Tet al.A fatal case of infection with a further reassortant, highly pathogenic avian influenza (HPAI) H5N6 virus in Yunnan, China. Infect Genet Evol 2016;40: 63–66.
PubMed Web of Science ®Google Scholar
Yang L, Zhu W, Li Xet al.Genesis and dissemination of highly pathogenic H5N6 avian influenza viruses. J Virol 2017;91: e02199–16.
PubMed Web of Science ®Google Scholar
Yamada S, Suzuki Y, Suzuki Tet al.Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 2006;444: 378–382.
PubMed Web of Science ®Google Scholar
Hatta M, Gao P, Halfmann Pet al.Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2001;293: 1840–1842.
PubMed Web of Science ®Google Scholar
Nguyen HT, Fry AM, Gubareva LV.Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods. Antivir Ther 2012;17: 159–173.
PubMed Web of Science ®Google Scholar

Human infections with novel reassortant H5N6 avian influenza viruses in China

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Human infections with novel reassortant H5N6 avian influenza viruses in China

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date